A&H Focal Recalls
21 recalls on record · February 7, 2018 to February 7, 2018 · Drugs
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Tiger King tablets, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls MACA gold tablets, 6800 mg, 10-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls LIEN CHAN FOR SEVEN DAYS capsules, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Power V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls YANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls MAX MAN capsules, 3000 mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Clalis capsules, 50mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls GOLD VIGRA capsules, 50mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls LANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls HARD TEN DAYS capsules, 4500mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Miraculous Evil Root capsules, 1200 mg, 6-count bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Indian God Lotion Spray Bottle, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms, making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.
February 7, 2018DrugsFDA
A&H Focal Inc. recalls Black Ant capsules, 4600mg, 4-count blister pack, labeling is in foreign language
Hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.